Insider Stock Trading History of Anzalone Christopher Richard


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Anzalone Christopher Richard since year 2005. The trader's CIK number is 1423029. At the time of this reporting, Anzalone Christopher Richard is the Chief Executive Officer of Arrowhead Pharmaceuticals, Inc. . (stock ticker symbol ARWR). See this page for all insider trading activities at Arrowhead Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Anzalone Christopher Richard since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2018-12-12 ARWR Arrowhead Pharmaceuticals, Inc. Sale 90,000 14.07 1,266,300
2018-11-09 ARWR Arrowhead Pharmaceuticals, Inc. Sale 81,500 14.65 1,193,975
2018-08-31 ARWR Arrowhead Pharmaceuticals, Inc. Sale 100,000 14.45 1,445,000
2018-09-04 ARWR Arrowhead Pharmaceuticals, Inc. Sale 64,834 14.45 936,851
2018-03-16 ARWR Arrowhead Pharmaceuticals, Inc. Sale 26,000 7.40 192,400
2018-03-13 ARWR Arrowhead Pharmaceuticals, Inc. Sale 100,000 7.43 743,000
2018-03-14 ARWR Arrowhead Pharmaceuticals, Inc. Sale 100,000 7.44 744,000
2018-03-15 ARWR Arrowhead Pharmaceuticals, Inc. Sale 100,000 7.41 741,000
2016-06-30 ARWR Arrowhead Pharmaceuticals, Inc. Option Ex 15,772 5.09 80,279
2014-10-15 ARWR Arrowhead Pharmaceuticals, Inc. Buy 16,000 6.32 101,120
2010-08-31 ARWR Arrowhead Pharmaceuticals, Inc. Buy 10,000 .89 8,900
2010-08-27 ARWR Arrowhead Pharmaceuticals, Inc. Buy 10,000 .89 8,900
2008-08-22 ARWR Arrowhead Pharmaceuticals, Inc. Buy 164,000 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Anzalone Christopher Richard (Chief Executive Officer of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.